Skip to content

Lipid Profile and Ultrasound Findings in Patients With Pancreaticobiliary Diseases

Lipid Profile and Ultrasound Findings in Patients With Pancreaticobiliary Diseases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06402305
Enrollment
200
Registered
2024-05-07
Start date
2024-05-02
Completion date
2024-05-05
Last updated
2024-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lipid Profile and Ultrasound Findings in Patients With Pancreaticobiliary Diseases

Brief summary

Gall stones happen is the most prevalent pathology affecting the biliary system due to its Physiological function of concentration of bile having a prevalence of 10%-15% and an incidence of 1.4% per year in the adult population of developed countries (Halldestam et al,. 2009). Women are more commonly affected by gall stone disease as compared to men (Attili et al,. 1995). Multiple risk factors responsible for the Gall stone formation include modifiable factors such as lifestyle factors (reduced physical activity, rapid weight loss, fasting, and oral contraceptives (Di Ciaula et al,. 2013); dietary factors (high fat, high cholesterol, high refined carbohydrates, and low fiber ; metabolic syndrome (obesity, diabetes mellitus, dyslipidemia, and hyperinsulinemia (Cuevas et al., 2004). Among all the above mentioned risk factors, serum lipids are considered to be the most important risk factor involved in the pathogenesis of Gall stone disease (Celika et al,. 2015). Hyperlipidemia is generally characterized by high serum levels of total cholesterol, triglycerides, low density lipoproteins (LDL-C), and low levels of high-density lipoprotein (HDL-C). Some studies have showed a significant association of hyperlipidemia with gall stones especially hypertriglyceridemia and increased LDL-C levels (Rao et al,. 2012). Acute pancreatitis (AP) is an inflammatory condition of the pancreas that originates within the pancreatic acinar cells and causes pancreatic necrosis, systemic inflammatory response syndrome, and multiple organ failure (Crockett et al,. 2013). According to The revised Atlanta classification system from 2012 ,AP is diagnosed on the basis of two of three criteria-typically belt-like abdominal pain, an elevated serum lipase level three times above the normal threshold, and radiological imaging signs of pancreatitis (Parniczky et al,.2016). Severe hypertriglyceridemia is a well-known cause of AP. Recent studies have suggested that elevated serum triglyceride and low high-density lipoprotein cholesterol (HDL-C) levels are associated with persistent organ failure in acute pancreatitis (Peng et al,. 2015). With the change of people's diet structure and lifestyle, the incidence and mortality of hypertriglyceridemic AP are increasing year by year and has surpassed alcohol as the second leading cause of AP (Carr et al,. 2016). Chronic pancreatitis is a syndrome characterized by chronic progressive pancreatic inflammation, fibrosis, and scarring, resulting in damage to and loss of exocrine (acinar), endocrine (islet cells), and ductal cells(Majumder S,. 2016)

Interventions

DIAGNOSTIC_TESTLipid profile

Abdominal ultrasound and lipid profile will be done

Sponsors

Alaa Mohamed Mostafa
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patients with age above 18 years * Patients with confirmed diagnosis of gall stones ,acute calcular cholecystitis ,calcular obstructive jaundice ,biliary stricture ,acute and chronic pancreatitis

Exclusion criteria

* Patients with renal failure, hemolytic diseases (hereditary spherocytosis, sickle cell anemia on history and CBC film). * Patients on antihyperlipidemic drugs .

Design outcomes

Primary

MeasureTime frameDescription
Lipid Profile and Ultrasound Findings in Patients with Pancreaticobiliary Diseases1 year* To evaluate the lipid profile and ultrasound findings in biliary diseases * To assess the lipid profile and ultrasound findings in pancreatic diseases

Countries

Egypt

Contacts

Primary ContactAlaa M Mostafa, Resident
Alaa.Mohamed2015m@med.sohag.edu.eg01099143258
Backup ContactAsmaa N Mohammed, Professor

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026